Commit To Buy Kindred Biosciences At $7.50, Earn 11.3% Annualized Using Options
January 27, 2020 at 13:15 PM EST
Investors eyeing a purchase of Kindred Biosciences Inc (KIN) stock, but tentative about paying the going market price of $9.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $7.50 strike, which has a bid at the time of this writing of 40 cents..